🇺🇸 FDA
Patent

US 7704701

Diagnosis of prostate cancer with SPAS-1 cancer antigen

granted A61KA61K2039/51A61K38/00

Quick answer

US patent 7704701 (Diagnosis of prostate cancer with SPAS-1 cancer antigen) held by The Regents of the University of California expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/51, A61K38/00